The UK aesthetic injectable market has undergone a significant shift over the past decade. Korean-manufactured aesthetic products — botulinum toxins, hyaluronic acid fillers and skin boosters, PDRN polynucleotides, lipolytic agents, and now exosomes — have moved from being unfamiliar imports to becoming the preferred clinical tools of a growing proportion of UK aesthetic practitioners.

Discover the differences between exosomes and PDRN, what to expect from skincare and professional treatments, and how to choose an option that fits your skin goals.

The aesthetic exosome market is growing rapidly and unevenly. Alongside genuinely well-characterised, rigorously manufactured Korean products with transparent documentation, the market contains preparations making compelling regenerative claims while providing minimal evidence of their actual content, source, or regulatory classification. For practitioners, the ability to evaluate exosome products on scientific and regulatory grounds is essential.